Talk Title: “PARP-1 Radiotracers for PET Imaging and Small Molecule Targeted Alpha Radiotherapeutics” PARP inhibitors (PARPi) have proven to be an important class of compounds for treating cancer patients having BRCA1/2 mutations or other deficiencies in homologous recombination repair. Unfortunately, ~50% of patients having BRCA1/2 mutations do not respond to PARPi, indicating that better biomarkers are needed to identify which patients are likely to benefit from this type of treatment…
Friday, Jan 29, 2021 10:00 AM – 11:00 AM CST |
Asset De-Risking in an Academic Setting
Radiometal Labeling and Chemistry of Standard Radionuclides (F-18, C-11, N-13 & O-15) Workshops and Scientific Session.
Pain, whether it is low back pain, headache, fibromyalgia, etc., is collectively now the #1 clinical problem in the world and, yet…
Animal study of Galuminox promising for lung disease; has potential uses in cancer, diabetes, COVID-19, other diseases
Tuesday, Jan 21, 2020 11:00 AM – 12:00 PM CST
US First-in-Man Regulatory Requirements: Nuts and Bolts for CMC Preparation
Presenter: Sally W. Schwarz, RPh, MS, BCNP
“Leveraging Immune Cell Diversity in Cardiovascular Disease”
Please join us to learn more about Regulatory and Clinical Imaging at our upcoming Workshops and Scientific Session.